Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp).
The virus is incapable of developing resistance to favipiravir even with long-term exposure on infected cells, as has been confirmed
A consortium of doctors and researchers from India, Brazil, Russia and South Africa will conduct a study on the epidemiological impact of the COVID-19 and tuberculosis pandemics in these countries, the Department of Science and Technology said on Wednesday.
Under this, joint research teams from these
Morepen Laboratories has started production of the test batch of Russia’s Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday. The first batch will be shipped to Gamaleya
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today announced the launch of production of the Russian Sputnik V vaccine against coronavirus.
The first batch produced at Panacea Biotec’s facilities at